Delivery Order SPE2DE24D0013-SPE2D625F9YX1
- Not listed
- The Defense Logistics Agency (DLA), under the Medical Supply Chain program, awarded a delivery order valued at $1,648.38 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on August 12, 2025. This firm fixed-price delivery order, without set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare agencies. The contract is scheduled for ultimate completion by August 19, 2025,...
- The Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $3,081.60 to Cepheid Inc. on August 7, 2025, for molecular diagnostic solutions. This firm fixed-price delivery order, designated 4569021301 and classified as GXCDIFF/EPI-10, is scheduled for completion by August 21, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The award carries no set-aside designation and represents a continuation of the federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $13,825.20 firm fixed-price delivery order to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. This delivery order, issued on September 19, 2025, with an ultimate completion date of September 26, 2025, carries no set-aside designation and represents a procurement of diagnostic equipment or testing supplies. The award leverages Cepheid's expertise in advanced...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $52,387.20 to Cepheid Inc. on September 26, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order (contract number 4569624736, XPRS4PLEX-10) carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The award represents a discrete purchase under one of Cepheid's larger indefinite delivery...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a firm fixed-price delivery order valued at $3,708.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation. This award represents a discrete delivery order under one of Cepheid's larger indefinite delivery vehicle contracts with the...
- The Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a $6,210.28 firm fixed-price delivery order to Cepheid Inc. on September 11, 2025, with an ultimate completion date of September 18, 2025. This contract carries no set-aside designation and represents a delivery order under a larger indefinite delivery vehicle (IDV) contract structure. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, is the prime contractor and...
- The U.S. Defense Logistics Agency (DLA), operating through its Medical Supply Chain division, awarded a $28,786 firm fixed-price delivery order to Cepheid Inc. on September 4, 2025, with completion scheduled for September 11, 2025. This non-set-aside contract is issued under Cepheid's existing Indefinite Delivery Vehicle (IDV) with the Veterans Integrated Service Network (VISN) 6, a $32.8 million single-award contract that extends through September 30, 2030. The work will be performed at...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a firm fixed-price delivery order valued at $1,190.28 from the Defense Logistics Agency (DLA), which operates under the Medical Supply Chain function. The contract, awarded on September 11, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. This delivery order is executed under a larger indefinite delivery vehicle (IDV) contract structure, enabling...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which carries no set-aside designation, has an ultimate completion date of July 25, 2025, and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with Cepheid's existing Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,040 on November 17, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems. This firm fixed-price delivery order, designated XPRS4PLEX-10 with completion slated for November 24, 2025, is issued under an existing Indefinite Delivery Contract framework. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an established...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F9YX1Delivery Order
The Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $4,791.90 to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, identified as 4568960199 / GXCT/NG-10, carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a discrete purchase of molecular diagnostic solutions from Cepheid, a leading manufacturer of advanced diagnostic systems and test kits specializing in infectious disease detection and clinical testing. Cepheid holds significant existing infrastructure for supporting federal diagnostic needs through two major Indefinite Delivery Vehicles with the VA, including a $32.8M contract with Veterans Integrated Service Network 6 and a $2.5M contract with Veterans Integrated Service Network 21. This delivery order likely draws upon one of these existing IDV vehicles or a related DLA contract vehicle, enabling the agency to procure Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, or maintenance services to support defense healthcare operations. As a prime contractor with established relationships across federal healthcare agencies, Cepheid provides comprehensive molecular diagnostic technologies for detecting conditions including COVID-19, influenza, RSV, and other infectious diseases critical to military medical readiness and veteran care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/1/25 |